Archive
Tag: IGF-1 LR3 Canada
Articles on IGF-1 LR3, the long-acting IGF-1 analogue developed for cell culture, and on sourcing it in Canada for laboratory use.
October 22, 2026
How the three-tier Ras-RAF-MEK-ERK cascade works, why signal duration rather than signal presence decides cell fate, why a pathway inhibitor can switch the pathway on, and which research compounds genuinely have published ERK data.
October 11, 2026
What mTOR is, how a soil bacterium from Easter Island led to it, the difference between mTORC1 and mTORC2, what the mouse lifespan data actually said, and why rapamycin is not the clean mTORC1 inhibitor it is often described as.
October 7, 2026
IGF-1 LR3 explained: the 83-amino-acid IGF-1 analogue built in Adelaide for cell culture, why it escapes binding proteins, what it's used for, and sourcing in Canada.